Page last updated: 2024-09-03

1-amino-3-(phosphonomethylene)cyclobutane-1-carboxylic acid and a 71623

1-amino-3-(phosphonomethylene)cyclobutane-1-carboxylic acid has been researched along with a 71623 in 1 studies

Compound Research Comparison

Studies
(1-amino-3-(phosphonomethylene)cyclobutane-1-carboxylic acid)
Trials
(1-amino-3-(phosphonomethylene)cyclobutane-1-carboxylic acid)
Recent Studies (post-2010)
(1-amino-3-(phosphonomethylene)cyclobutane-1-carboxylic acid)
Studies
(a 71623)
Trials
(a 71623)
Recent Studies (post-2010) (a 71623)
6002702

Protein Interaction Comparison

ProteinTaxonomy1-amino-3-(phosphonomethylene)cyclobutane-1-carboxylic acid (IC50)a 71623 (IC50)
Cholecystokinin receptor type AHomo sapiens (human)1.9
Cholecystokinin receptor type ACavia porcellus (domestic guinea pig)1.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson, RL; Koerner, JF; Kroona, HB; Peterson, NL1

Other Studies

1 other study(ies) available for 1-amino-3-(phosphonomethylene)cyclobutane-1-carboxylic acid and a 71623

ArticleYear
Activity of the conformationally rigid 2-amino-4-phosphonobutanoic acid (AP4) analogue (RS)-1-amino-3-(phosphonomethylene)cyclobutane-1-carboxylic acid (cyclobutylene AP5) on evoked responses in the perforant pathway of rat hippocampus.
    Brain research, 1992, Jan-31, Volume: 571, Issue:1

    Topics: Animals; Cyclobutanes; Dose-Response Relationship, Drug; Evoked Potentials; Hippocampus; In Vitro Techniques; Male; Molecular Conformation; Neural Pathways; Organophosphorus Compounds; Osmolar Concentration; Rats; Rats, Inbred Strains; Tetragastrin

1992